Zura Bio Ltd. (ZURA)
4.04
-0.12
(-2.88%)
USD |
NASDAQ |
Sep 25, 16:00
4.045
0.00 (0.00%)
After-Hours: 19:59
Zura Bio Total Liabilities (Quarterly) : 16.32M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 16.32M |
| March 31, 2026 | 11.74M |
| December 31, 2025 | 12.41M |
| September 30, 2025 | 25.49M |
| June 30, 2025 | 18.70M |
| March 31, 2025 | 21.09M |
| December 31, 2024 | 19.51M |
| September 30, 2024 | 18.24M |
| June 30, 2024 | 17.44M |
| March 31, 2024 | 16.27M |
| December 31, 2023 | 21.29M |
| Date | Value |
|---|---|
| September 30, 2023 | 18.96M |
| June 30, 2023 | 22.01M |
| March 31, 2023 | 6.53M |
| December 31, 2022 | 7.760M |
| September 30, 2022 | 7.404M |
| June 30, 2022 | 7.416M |
| March 31, 2022 | 9.906M |
| December 31, 2021 | 10.35M |
| September 30, 2021 | 11.83M |
| June 30, 2021 | 0.1919M |
| March 31, 2021 | 0.1036M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| NovelStem International Corp. | 2.097M |
| Brainstorm Cell Therapeutics, Inc. | 12.38M |
| Summit Therapeutics, Inc. | 122.20M |
| Kezar Life Sciences, Inc. | 2.762M |
| Protara Therapeutics, Inc. | 14.78M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 213.40M |
| Shareholders Equity (Quarterly) | 197.08M |
| Current Ratio | 12.90 |